Literature DB >> 4544603

Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.

S Worlledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4544603

Source DB:  PubMed          Journal:  Scand J Respir Dis Suppl        ISSN： 0080-6730


× No keyword cloud information.
  4 in total

1.  Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors:  Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

2.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.

Authors:  A Criel; R L Verwilghen
Journal:  Blut       Date:  1980-02

Review 4.  Drug-induced uveitis: A review.

Authors:  Manisha Agarwal; Parthopratim Dutta Majumder; Kalpana Babu; Vinaya Kumar Konana; Mallika Goyal; Sara Touhami; Dinu Stanescu-Segall; Bahram Bodaghi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.